2-(benzimidazol-1-id-2-yl)-1,3-oxazole;2-(benzimidazol-1-id-2-yl)-1,3-thiazole;pentakis(iridium);2-(1-methylimidazol-2-yl)benzimidazol-1-ide;2-pyridin-2-ylimidazo[4,5-b]pyridin-3-ide;2-(4,4,5,5-tetramethylimidazol-3-id-2-yl)pyridine
C54H44Ir5N17OS-5 — CID 158245176
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(benzimidazol-1-id-2-yl)-1,3-oxazole;2-(benzimidazol-1-id-2-yl)-1,3-thiazole;pentakis(iridium);2-(1-methylimidazol-2-yl)benzimidazol-1-ide;2-pyridin-2-ylimidazo[4,5-b]pyridin-3-ide;2-(4,4,5,5-tetramethylimidazol-3-id-2-yl)pyridine
2-(benzimidazol-1-id-2-yl)-1,3-oxazole;2-(benzimidazol-1-id-2-yl)-1,3-thiazole;pentakis(iridium);2-(1-methylimidazol-2-yl)benzimidazol-1-ide;2-pyridin-2-ylimidazo[4,5-b]pyridin-3-ide;2-(4,4,5,5-tetramethylimidazol-3-id-2-yl)pyridine (PubChem CID 158245176) has the molecular formula C54H44Ir5N17OS-5 and a molecular weight of 1940.22 g/mol. Its IUPAC name is 2-(benzimidazol-1-id-2-yl)-1,3-oxazole;2-(benzimidazol-1-id-2-yl)-1,3-thiazole;pentakis(iridium);2-(1-methylimidazol-2-yl)benzimidazol-1-ide;2-pyridin-2-ylimidazo[4,5-b]pyridin-3-ide;2-(4,4,5,5-tetramethylimidazol-3-id-2-yl)pyridine.
Molecular Properties
| Compound Name | 2-(benzimidazol-1-id-2-yl)-1,3-oxazole;2-(benzimidazol-1-id-2-yl)-1,3-thiazole;pentakis(iridium);2-(1-methylimidazol-2-yl)benzimidazol-1-ide;2-pyridin-2-ylimidazo[4,5-b]pyridin-3-ide;2-(4,4,5,5-tetramethylimidazol-3-id-2-yl)pyridine |
|---|---|
| PubChem CID | 158245176 |
| Molecular Formula | C54H44Ir5N17OS-5 |
| Molecular Weight | 1940.22 g/mol |
| Exact Mass | 1943.18 |
| IUPAC Name | 2-(benzimidazol-1-id-2-yl)-1,3-oxazole;2-(benzimidazol-1-id-2-yl)-1,3-thiazole;pentakis(iridium);2-(1-methylimidazol-2-yl)benzimidazol-1-ide;2-pyridin-2-ylimidazo[4,5-b]pyridin-3-ide;2-(4,4,5,5-tetramethylimidazol-3-id-2-yl)pyridine |
| SMILES | CC1(C)N=C(c2ccccn2)[N-]C1(C)C.Cn1ccnc1-c1nc2ccccc2[n-]1.[Ir].[Ir].[Ir].[Ir].[Ir].c1ccc(-c2nc3cccnc3[n-]2)nc1.c1ccc2[n-]c(-c3ncco3)nc2c1.c1ccc2[n-]c(-c3nccs3)nc2c1 |
| InChI | InChI=1S/C12H16N3.C11H9N4.C11H7N4.C10H6N3O.C10H6N3S.5Ir/c1-11(2)12(3,4)15-10(14-11)9-7-5-6-8-13-9;1-15-7-6-12-11(15)10-13-8-4-2-3-5-9(8)14-10;1-2-6-12-8(4-1)11-14-9-5-3-7-13-10(9)15-11;2*1-2-4-8-7(3-1)12-9(13-8)10-11-5-6-14-10;;;;;/h5-8H,1-4H3;2-7H,1H3;1-7H;2*1-6H;;;;;/q5*-1;;;;; |
| InChIKey | NLGUQXOHQYRGMT-UHFFFAOYSA-N |
| XLogP | 10.16 |
| TPSA | 229.83 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 78 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1940.22 |
| LogP ≤ 5 | 10.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158245176 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.